Certolizumab pegol in the treatment of axial spondyloarthritis

E Anderson: Literature review, and writing of sections including abstract, introduction, clinical efficacy, conclusion, executive summary and editing. S Beier: Writing of sections including introduction to compound, pharmacology and regulatory affairs. J Desmarais: Literature review and writing of sections including real-world evidence, safety and tolerability and editing.

Comments (0)

No login
gif